How might AI amplify epidemiological insight into neurodegenerative and systemic disease? JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, speaks with Fang Fang, MD, PhD, professor at Karolinska Institutet and head of the Integrative Epidemiology group. Drawing on Fang Fang's work in ALS, Parkinson disease, dementia, energy metabolism, immune modulation, and gut microbiome interactions, their conversation probes how AI methods might help map disease trajectories, identify prognostic markers, and ultimately support precision prevention and translational research, while preserving scientific rigor and interpretability. Related Content:
